Schmidt’s syndrome: a difficult diagnosis in the Latin American context

Authors

  • Claudia Barreda-Velit <p>Facultad de Ciencias de la Salud, Escuela de Medicina, Departamento de Investigaci&oacute;n. Lima</p>
  • Rodrigo Salcedo-Pereda <p>Facultad de Ciencias de la Salud, Escuela de Medicina, Departamento de Investigaci&oacute;n. Lima</p>
  • Jesús Ticona <p>Seguro Social del Estado Peruano (EsSalud), Hospital Nacional Edgardo Rebagliati Martins, Servicio de Endocrinolog&iacute;a. Lima</p>

Keywords:

Polyendocrinopathies, Autoimmune, Addison Disease, Adrenal Gland Diseases, Hypothyroidism

Abstract

Background: Schmidt’s syndrome, also known as poliglandular autoimmune syndrome type 2, is a rare disease that has a prevalence between 1.5-4.5 cases per 100 000 inhabitants. The diagnosis consists in the concomitant presentation of Addison disease, autoimmune thyroid disease and other autoimmune endocrinological conditions. The aim of this paper is to describe a case of Schmidt’s syndrome in the peruvian context and to analyze the difficulties in the diagnosis.

Clinical case: We present the case of a 43-year-old woman that presents to the emergency room with headache, nausea, vomits and a “syncope episode”. The patient had a history of secondary amenorrhea, Addison disease, hypothyroidism, osteoporosis and diabetes mellitus type 2. Physical exam showed hyperpigmentation, hypotension and bradycardia. Lab exams demonstrated leukocytosis, hyponatremia, hyperglycemia, and compensated metabolic alkalosis. The emergency management consisted on rehydration, corticoids and insulin. During the hospital stance, exams included follicle stimulation hormone increasement and vaginal echography determined uterine hypoplasia. The patient was discharged one month later with Schmidt’s syndrome, based on autoimmune thyroiditis, Addison’s disease and hypergonadotrophic hypogonadism. In a two week later control, the patient was asymptomatic  with  levothyroxine, fluodrocortisone, estradiol and insulin treatment.

Conclusions: In our context, Schmidt’s syndrome is a very rare disease, which leads to a late diagnosis and difficult management.

Downloads

Download data is not yet available.

References

Betterle C, Dal Para C, Mantero F, Zanchetta R. Autoimmune adrenal insufficiency and autoinmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev. 2002;23(3):327-64. DOI: 10.1210/edrv.23.3.0466.

 

Eisenbarth GS, Gottlieb PA. Autoimmune polyendocrine syndromes. N Engl J Med. 2004;350:2068-79. DOI: 10.1056/NEJMra030158.

 

Urbina-Vázquez A, Rodríguez-Lobato E, Aquino-Matus J, Ramírez-Hobak L. Síndrome poliglandular autoinmunitario tipo II (síndrome de Schmidt): enfermedad de Addison y tiroiditis de Hashimoto asociado con vitiligo. Med Int Méx. 2017;33(2):241-245.

 

Pereira N, Rau C, Araya V. Caso clínico: síndrome poliglandular autoinmune tipo II, forma de presentación en un paciente adulto. Rev Hosp Clin Univ Chile. 2008;19:149-55.

 

Fortich-Revollo AJ, Mora-García G, Fortich-Salvador A, Malambo-García D, Ramos-Clason EC, Franco-García S. Síndrome polyglandular autoimmune tipo II en el Hospital Universitario del Caribe. Cartagena, Colombia. Rev Cienc Biomed. 2011;2(1):54-62.

 

Pila-Pérez R, Pila-Peláez R, Prieto H, Víctor A, Torres E, Rodriguez M. Síndrome poliglandular autoinmune tipo II: presentación de un caso. Archivo médico de Camagüey. 2013;17(3):301-11.

 

Dittmar M, Kahaly GJ. Polyglandular autoimmune syndromes: immunogenetics and long-term follow-up. J Clin Endocrinol Metab. 2003;88(7):2983-92. DOI: 10.1210/jc.2002-021845.

 

Fatmaa M, Mounaa E, Raoufb H, Hajerc F, Hatem M, Mohammed A. Autoimmune Polyglandular Syndrome Type II: Epidemiological, Clinical and Immunological Data. J Endocrinol Metab. 2014;4(4):101-109. DOI:10.14740/jem227w.

 

Weyermann D, Spinas G, Roth S, Guglielmetti M, Viollier E, Staub JJ. Combined endocrine autoimmune syndrome-incidence, forms of manifestation and clinical significance. Schweiz Med Wochenschr. 1994;124(44):1971-75.

 

Cutolo M. Autoimmune polyendocrine syndromes. Autoimmun Rev. 2014;13(2):85-9. DOI: 10.1016/j.autrev.2013.07.006

 

Alcalde-Rabanal JE, Lazo-González O, Nigenda G. Sistemas de salud de Perú. Salud Pública de México. 2011;53(2):243-254.

 

Letelier MC. Sindromes endocrinos autoinmunes: cuándo sospechar y estudiar un síndrome poliglandular. Rev Med Clin Condes. 2013;24(5):784-89.

 

Brix TH, Hansen PS, Kyvik KO, Hegedüs L. Aggregation of thyroid autoantibodies in first-degree relatives of patients with autoimmune thyroid disease is mainly due to genes: a twin study. Clin Endocrinol (Oxf). 2004;60(3):329-34. DOI: 10.1111/j.1365-2265.2004.01983.x.

 

Hrda P, Sterzl I, Matucha P, Korioth F, Kromminga A. HLA antigen expression in autoimmune endocrinopathies. Physiol Res. 2004;53(2):191-97.

 

Michels AW, Gottlieb PA. Autoimmune polyglandular syndromes. Nat Rev Endocrinol. 2010;6:270-77. DOI: 10.1038/nrendo.2010.40.

 

Papierska L, Rabijewski M. Delay in diagnosis of adrenal insufficiency is a frequent cause of adrenal crisis. Int Jour Endocrin. 2013. DOI: 10.1155/2013/482370.

 

Bleicken B, Hahner S, Ventz M, Quinkler M. Delayed diagnosis of adrenal insufficiency is common: a cross-sectional study in 216 patients. Am J Med Sci. 2010;339(6):525-31. DOI: 10.1097/MAJ.0b013e3181db6b7a.

Published

2018-07-09

Issue

Section

Clinical Cases